Company profile for Centessa Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Centessa Pharmaceuticals aims to improve R&D productivity by scaling the asset centric model of a smaller company to that of a larger enterprise. In doing so, Centessa represents a new kind of pharmaceutical company that operates in a bottom-up organizational structure with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts. At its inception, Centessa consists of 10 subsi...
Centessa Pharmaceuticals aims to improve R&D productivity by scaling the asset centric model of a smaller company to that of a larger enterprise. In doing so, Centessa represents a new kind of pharmaceutical company that operates in a bottom-up organizational structure with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts. At its inception, Centessa consists of 10 subsidiary companies advancing a portfolio of high conviction programs with strong biological validation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Cambridge, Massachusetts
Telephone
Telephone
+1.617.468.5770
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3185855/0/en/Centessa-Pharmaceuticals-Announces-Pricing-of-250-000-000-Public-Offering-of-American-Depositary-Shares.html

GLOBENEWSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/11/11/3185755/0/en/Centessa-Pharmaceuticals-Announces-Proposed-Public-Offering-of-American-Depositary-Shares.html

GLOBENEWSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/11/07/3183612/0/en/Centessa-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
07 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181265/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-for-the-Third-Quarter-of-2025-and-Provides-Update-on-Potential-Best-in-Class-Orexin-Receptor-2-OX2R-Agonist-Program.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/08/12/3131564/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-and-Business-Highlights-for-the-Second-Quarter-of-2025.html

GLOBENEWSWIRE
12 Aug 2025

https://www.globenewswire.com/news-release/2025/07/04/3110212/0/en/Nxera-Pharma-to-Receive-US-4-8-Million-in-Milestone-Payments-Following-Centessa-s-Initiation-of-Clinical-Development-of-ORX142-a-Novel-Orexin-Receptor-2-OX2R-Agonist.html

GLOBENEWSWIRE
05 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty